Interesting company that is studying the use of monoclonal antibodies for Hodgkin's disease Seattle Genetics: News Release. Related articles More Effective, Safer Protection Against Osteoporosis? (medicalnewstoday.com) Clinical trial for rabies monoclonal antibody (medicalxpress.com) Invisible Sentinel Announces Product Launch of Its Foodborne Pathogen Specific Monoclonal Antibodies (sys-con.com) Billionaire's biotech seals second deal with Synthetic Biologics (fiercebiotech.com) Lymph … Continue reading Seattle Genetics studies monoclonal antibodies for Hodgkin’s disease
You must be logged in to post a comment.